-
Hybrid Event for Northern New Englanders: Addressing the Intersection of Pain Management and Opioid Use, September 29, 2023
The New England Opioid Response Network and Northeast Node of the National Drug Abuse Treatment Clinical Trials Network are pleased to bring together experts in the fields of pain and opioid use at a Regional Summit to be held in Concord, New Hampshire, on Friday, September 29, 2023. This event is intended for Northern New England audiences (Maine, New Hampshire, and Vermont). We invite all who provide care to patients that experience pain (acute or chronic), use opioids, or have opioid use disorder, to attend. This interdisciplinary team-based training will provide evidence-based solutions to managing pain and opioid use. In-person attendance is encouraged but limited – register now to reserve your seat!…
-
News from the Greater Southern California Node
-
News from the New England Consortium Node
NIDA News Release Buprenorphine initiation in the ER found safe and effective for individuals with OUD who use fentanyl. NIDA News, March 30, 2023. Referencing findings: D’Onofrio G, Hawk KF, Perrone J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023;6(3):e236108. doi:10.1001/jamanetworkopen.2023.6108 New Publication Kropp FB, Smid MC, Lofwall MR, Wachman EM, Martin PR, Murphy SM, Wilder CM, Winhusen TJ. Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study. J Subst Use Addict Treat. 2023 Apr 4;149:209030. doi: 10.1016/j.josat.2023.209030. Epub ahead of print. PMID: 37023858. Posted April…
-
News from the Western States Node
CTN Western States Node investigators Dan Hartung and Elizabeth Waddell recently published findings from their CDC-funded project, Reducing Overdose After Release from Incarceration (PI: Waddell) that demonstrate risk of fatal and non-fatal opioid overdose risk is 10x greater among Oregon adults releasing from prison than in the state’s general population. Risk is even higher among women, those with documented substance use disorder and mental health treatment needs, and in the two weeks post release. Read the article in JSAT here. These findings are already driving policy discussions in Oregon and were covered in local media, emphasizing the need to start treatment prior to release and to allocate resources for more intentional…
-
Webinar: The Greater Intermountain Node (GIN): Where We Were, Where We Are, and Where We Will Be (April 18, 12pm MT)
Presenter: Adam J. Gordon, MD, MPH, FACP, DFASAMApril 18, 2023 | 12:00-1:00 PM MST In this presentation, Dr. Gordon will describe the origination, present status, and future opportunities of the CTN Greater Intermountain Node (GIN). He will describe the mission and aims of GIN, as well as the three studies originating from the Node and six studies hosted by it. Dr. Gordon will emphasize the remarkable research and clinical collaboration across the University of Utah campus and greater Intermountain area. He will also discuss the robust mentored training of the GIN and look forward to how the GIN will evolve in the future. Connection information: Zoom ID: 931 8327 3330,…
-
Webinar: Injectable XR Buprenorphine: A Better Mousetrap or a Paradigm Shift in MOUD (April 6, Northeast Node)
Join the CTN Northeast Node on April 6, 2023 (12pm-1pm ET) for the latest in their Science Series: Injectable XR Buprenorphine: A Better Mousetrap or a Paradigm Shift in MOUD? with Eva Quirion, NP, PhD This presentation will explore the science behind extended release (XR) buprenorphine and field experiences in the use of XR buprenorphine in a primary care setting. This talk will also address ways to bring this medication to patients and if this treatment makes financial sense. 1.0 AMA PRA Category 1 CME available! Join the Zoom meeting here (no registration necessary)
-
News from the Northeast Node: Science Series Update
January 8, 2023 Northeast Node Science Series kicks off its ’22-23 Academic Year with an in-depth review of cannabis as a potential pharmacological adjunct to MOUD In November 2022, the Northeast Node welcomed Dr. Ziva Cooper of the UCLA Center for Cannabis & Cannabinoids to kick off the Node’s ’22-23 Academic Year Science Series. Dr. Cooper’s presentation, “Cannabis and Opioids: Promising pharmacology to address the opioid epidemic?” gave a brief overview of cannabis and the pharmacology of phytocannabinoids. Preclinical studies and randomized controlled trials have examined the potential for cannabinoids to modulate opioid effects and withdrawal symptoms, opioid abuse liability, and opioid analgesia. Dr. Cooper reviewed basic cannabinoid pharmacology and…
-
News from the Florida Node Alliance
Dr. José Szapocznik, Multiple PI of CTN’s Florida Node Alliance and Professor and Chair Emeritus at the Department of Public Health Sciences, of the University of Miami Miller School of Medicine, was elected to the Academy of Science, Engineering and Medicine of Florida (ASEMFL), an evidence-based scientific advisory body focused on providing expert advice to state government and other organizations on current and future challenges facing the world and Florida. Recognizing four and a half decades of important contributions to developing and testing interventions in the areas of mental health and drug abuse, ASEMFL elected Dr. Szapocznik for his “exemplary contributions to prevention science and globally impactful substance use prevention for…
